LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis. Shen Y, Yan J, Li L, Sun H, et al. J Clin Invest 2024;134:e177357.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shen Y, Yan J, Li L, Sun H, et al. LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis. J Clin Invest 2024;134:e177357.
PMID: 39145451